CRMD R&D to Revenue
Cormedix Inc · R&D to Revenue
CRMD R&D to Revenue
Latest reported6.56%period ending
CRMD Quarterly R&D/Revenue (0.00% → 6.56%)
Latest values, visible window
High-resolution chart · PNG
CRMD r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 6.5574% | |
| 5.6597% | |
| 6.6868% | |
| 4.8886% | |
| 6.1472% | |
| 8.1686% | |
| 5.5326% | |
| 6.347% | |
| 80.7558% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 9,572.4934% | |
| 34,315.212% | |
| 15,101.261% | |
| 29,957.923% | |
| 5,736.509% | |
| 12,448.0886% | |
| 30,767.9526% | |
| 2,986.9727% | |
| 4,118.3027% | |
| 3,144.8667% | |
| 34,575.7587% | |
| 3,338.2626% | |
| 10,803.5312% | |
| 4,234.8261% | |
| 8,449.8015% | |
| 1,756.3448% | |
| -16,390.5365% | |
| 2,225.1765% | |
| 87,408.4889% | |
| 35,676.1827% | |
| 9,141.183% | |
| 9,847.3352% | |
| 3,737.7534% | |
| 12,447.9057% | |
| 3,312.9318% | |
| 15,388.6594% | |
| 16,794.6157% | |
| 5,044.0341% | |
| 6,472.8144% | |
| 4,908.5264% | |
| 1,498.3271% | |
| 3,948.679% | |
| 590.2157% | |
| 558.1282% | |
| 432.7544% | |
| 2,892.8788% | |
| -9,455.45% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |